ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.4729
Delayed Data
As of May 05
 -0.007 / -1.46%
Today’s Change
0.43
Today|||52-Week Range
1.45
-35.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization20.4K45.8K50.4K47.7K
 
 
 
 
 
 
Operating ExpensesGross Income-20.4K-45.8K-50.4K-47.7K
 
 
 
 
 
General Expenses8.6M11.8M9.4M9.8M
 
 
 
 
 
Research And Development5.0M7.7M5.3M6.0M
 
 
 
 
 
Total Operating Expenses8.6M11.8M9.5M9.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.6M-11.8M-9.5M-9.9M
 
 
 
 
 
Extraordinary Credit2.9M0.00642.4K529.8K
 
 
 
 
Extraordinary Charge0.00-2.3M0.00--
 
 
Other Expenses0.00-397.3K0.00-62.7K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-14.5M-8.8M-9.4M
 
 
 
 
 
Net Income-5.7M-14.5M-8.8M-9.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.5M41.8M54.3M59.9M
 
 
 
 
 
Shares To Calculate EPS Diluted27.5M41.8M54.3M59.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.35-$0.16-$0.16
 
 
 
 
 
EPS Diluted-$0.21-$0.35-$0.16-$0.16
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account